首页> 美国卫生研究院文献>Open Medicine >A confusing case report of pulmonary langerhans cell histiocytosis and literature review
【2h】

A confusing case report of pulmonary langerhans cell histiocytosis and literature review

机译:肺部Langerhans细胞组织细胞增生症一例令人困惑的报道并复习文献

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pulmonary Langerhans Cell Histiocytosis (PLCH) is a rare disease. From the insidious onset and nonspecific manifestations, it is difficult to diagnose PLCH. To help improve the diagnosis and therapy options of adult PLCH, we present this case report and literature review about a confusing case of PLCH. In this report, we present a 37-year-old male PLCH case that was negative for CD1a and S100 expression. Smoking cessation and use of prescribed Spiriva appeared to improve the patient’s symptoms. To the best of our knowledge, this is the first reported case of PLCH in which improved symptoms were seen with the use of Spiriva alone.The mechanism is not clear, but potentially has some relationship with dilating the airway, decreasing the mucous hypersecretion and promoting anti-inflammatory pathways. From this patient’s case, we may be able to find more cases to then find other first line therapies for PLCH patients.
机译:肺朗格汉斯细胞组织细胞增生症(PLCH)是一种罕见的疾病。从隐匿性发作和非特异性表现来看,难以诊断PLCH。为了帮助改善成人PLCH的诊断和治疗选择,我们提供了此病例报告和有关混淆性PLCH病例的文献综述。在本报告中,我们介绍了一个37岁的男性PLCH病例,该病例的CD1a和S100表达阴性。戒烟和使用处方的Spiriva似乎可以改善患者的症状。据我们所知,这是首次报告的PLCH病例,仅使用Spiriva即可改善症状,其机制尚不清楚,但可能与扩张气道,减少粘液过度分泌和促进有一定关系。抗炎途径。从这个病人的案例来看,我们也许能够找到更多的案例,然后为PLCH病人找到其他一线疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号